Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2014-09-16

Original market date: See footnote 1

2014-09-16

Product name:

COMBIVENT RESPIMAT

Description:

FOR ORAL INHALATION. FOR USE ONLY WITH COMBIVENT RESPIMAT INHALER

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02419106

Product Monograph/Veterinary Labelling:

Date: 2019-11-07 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

BOEHRINGER INGELHEIM (CANADA) LTD LTEE
5180 South Service Road
Burlington
Ontario
Canada  L7L 5H4

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Inhalation

Number of active ingredient(s):

2

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

12:12.08.12   SELECTIVE BETA 2-ADRENERGIC AGONISTS ,  48:12.04.12   SELECTIVE BETA 2-ADRENERGIC AGONISTS ,  12:08.08   ANTIMUSCARINICS ANTISPASMODICS

Anatomical Therapeutic Chemical (ATC): See footnote 4

R03AL02  SALBUTAMOL AND IPRATROPIUM BROMIDE

Active ingredient group (AIG) number:See footnote 5

0232902002

List of active ingredient(s)
Active ingredient(s) Strength
IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE MONOHYDRATE) 20 MCG / ACT
SALBUTAMOL (SALBUTAMOL SULFATE) 100 MCG / ACT

Application information

Related information

Contact us

Version 3.8.0
Date modified: